JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Financial Incentives to Reduce Pediatric Tobacco Smoke Exposures

Not Applicable

Completed

Conditions: Tobacco Smoking
Asthma
Incentives

Interventions: Behavioral: Incentive plan
Behavioral: Smoking cessation

First Posted Date: 2017-04-04

Last Posted Date: 2018-11-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 147

Registration Number: NCT03099811

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)

Phase 1

Completed

Conditions: HPV-Related Anal Intraepithelial Neoplasia
AIN2/3
Artesunate
Alternative Treatment
Anal Dysplasia
Precancerous Conditions
Human Papilloma Virus

Interventions: Drug: Artesunate Suppositories

First Posted Date: 2017-04-04

Last Posted Date: 2021-11-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 18

Registration Number: NCT03100045

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis

Phase 2

Completed

Conditions: Knee Osteoarthritis

Interventions: Drug: Blinded study medication

First Posted Date: 2017-04-04

Last Posted Date: 2024-12-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 58

Registration Number: NCT03098563

Locations: 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States

Transforming Robot-mediated Telerehabilitation: Citizen Science for Rehabilitation

Not Applicable

Recruiting

Conditions: Hemiparesis
Stroke

Interventions: Behavioral: Output-Focus Condition
Behavioral: Input-Focus Condition

First Posted Date: 2017-03-30

Last Posted Date: 2024-12-27

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 40

Registration Number: NCT03096262

Locations: 🇺🇸
Matthew Bird, Baltimore, Maryland, United States

Fetoscopic Repair of Isolated Fetal Spina Bifida

Not Applicable

Active, not recruiting

Conditions: Chiari Malformation Type 2
Neural Tube Defects
Spinal Dysraphism
Myelomeningocele
Congenital Abnormality
Spina Bifida

Interventions: Device: Fetoscopy

First Posted Date: 2017-03-27

Last Posted Date: 2024-12-12

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT03090633

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance

Not Applicable

Active, not recruiting

Conditions: Kidney
Living Donors
Nephrectomy

Interventions: Other: Financial Incentive

First Posted Date: 2017-03-27

Last Posted Date: 2024-12-09

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 320

Registration Number: NCT03090646

Locations: 🇺🇸
University of Maryland Medical Center Transplant Center, Baltimore, Maryland, United States
🇺🇸
The Johns Hopkins Hospital Comprehensive Transplant Center, Baltimore, Maryland, United States

Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients

Early Phase 1

Completed

Conditions: Lumbar Spinal Stenosis
Lumbar Spinal Instability
Lumbar Spine Degeneration

Interventions: Drug: Standard analgesia use [Oxygen]
Drug: Multi-modal pain management [Acetaminophen + Gabapentin]
Drug: Standard analgesia use [Hydromorphone]
Drug: Multi-modal pain management [Fentanyl]
Drug: Standard analgesia use [Volatile Anesthesia]
Drug: Multi-modal pain management [Intravenous Ketamine]
Drug: Standard analgesia use [Fentanyl]
Drug: Multi-modal pain management [Valium + Gabapentin]

First Posted Date: 2017-03-23

Last Posted Date: 2018-10-16

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 49

Registration Number: NCT03088306

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study

Phase 1

Completed

Conditions: HIV Prevention

Interventions: Drug: DuoGel

First Posted Date: 2017-03-17

Last Posted Date: 2019-10-14

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 10

Registration Number: NCT03082690

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Intranasal Insulin for the Treatment of HAND

Phase 1

Terminated

Conditions: HIV Dementia
HIV-Associated Cognitive Motor Complex

Interventions: Drug: Placebo, intranasal
Drug: Insulin, intranasal

First Posted Date: 2017-03-16

Last Posted Date: 2021-07-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 21

Registration Number: NCT03081117

Locations: 🇺🇸
The Johns Hopkins Institute for Clinical and Translational Research, Adult Outpatient Clinical Research Unit, Baltimore, Maryland, United States

Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index Cases

Not Applicable

Completed

Conditions: Tuberculosis

Interventions: Other: Clinical based Decisions
Other: Symptom -based Screening(Child Contacts)

First Posted Date: 2017-03-09

Last Posted Date: 2020-03-04

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 4054

Registration Number: NCT03074799

Locations: 🇿🇦
PHRU, Klerksdorp, Matlosana, South Africa

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy